AI-driven predictive biomarker discovery with contrastive learning to improve clinical trial outcomesGustavo Arango-Argoty, Etai Jacob, Damián E. Bikiel et al.|Cancer Cell|2025Cited by 40
Body Composition in Advanced Non-Small Cell Lung Cancer Treated With ImmunotherapyTafadzwa L. Chaunzwa, Hugo J.W.L. Aerts, Damián E. Bikiel et al.|JAMA Oncology|2024Cited by 36
AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial OutcomesGustavo Arango-Argoty, Etai Jacob, Gerald J. Sun et al.|medRxiv|2024Cited by 2
AI-based predictive biomarker discovery via contrastive learning retrospectively improves clinical trial outcomeEtai Jacob, Kaitlin M. Smith, Gustavo Arango-Argoty et al.|Research Square|2024Cited by 2
Machine learning modeling of patient health signals informs long-term survival on immune checkpoint inhibitor therapyGerald J. Sun, Etai Jacob, Gustavo Arango-Argoty et al.|iScience|2024Cited by 2